As previously reported, Jefferies downgraded Avantor (AVTR) to Hold from Buy with a price target of $12, down from $20. Valuation is “compelling,” but the firm says turnaround hopes have faded as it now sees significant risks around pricing, margins and growth coming out of the company’s Q2 report. The magnitude of price cuts being used to protect Lab share is “jarring and likely puts a lid on margin expansion,” the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: